Scarica l'app Stockscreener
839.96
14.30%
105.06
Dopo l'orario di chiusura:
844.00
4.04
+0.48%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LLY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Lilly Eli Co Borsa (LLY) Ultime notizie
Lilly Blasts Compounders' 'Scattershot' Bid To Reverse FDA - Law360
Eli Lilly (LLY) Boosts U.S. Manufacturing with Promising Weight-Loss Pill - GuruFocus
Eli Lilly plans to make weight-loss pill in U.S. amid Trump’s reshoring push (NYSE:LLY) - Seeking Alpha
Eli Lilly (NYSE:LLY) Advances Diabetes Treatment And Partners With BigHat On Antibody Discovery - Yahoo Finance
Lilly says new daily pill can help with weight loss, blood sugar - NewsNation
Daily GLP-1 Pill Shows Promise for Diabetes and Weight Loss, Eli Lilly Says - Verywell Health
First Weight-Loss Pill From Lilly Shows Promising Results - Wyoming Tribune Eagle
Lilly Promises to Make Weight-Loss Pill in US in Reshoring Push - Bloomberg.com
Eli Lilly and Company (LLY): One of the Best Long Term Stocks to Buy According to Billionaires - Insider Monkey
Eli Lilly and BigHat Biosciences ink AI antibody discovery deal - Pharmaceutical Technology
Top-Line Results Positive for Lilly’s Oral Orforglipron - Medscape
Lilly's orforglipron consistent with injectable GLP-1 medicines in Phase 3 trial - MSN
Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar - The New York Times
Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (April 2025) - 24/7 Wall St.
Where Will Eli Lilly Be in 5 Years? - The Motley Fool
Atopic Dermatitis Drugs Market Forecast 2025-2034 | Rising Drug Approvals and Clinical Trial Successes Propel Revenue Growth, Making Atopic Dermatitis a High-Growth Market - GlobeNewswire Inc.
Why Eli Lilly and Company (LLY) is Skyrocketing? - Insider Monkey
Eli Lilly (LLY) Surges on Promising Obesity Pill Trial Results - GuruFocus
Eli Lilly develops groundbreaking new weight-loss pill - NBC News
Eli Lilly (LLY) Shares Surge on Promising New Weight-Loss Pill - GuruFocus
Lilly Soars After Pill Shows Its as Good as Ozempic - Bloomberg.com
Eli Lilly's obesity drug trial shows 7.3kg weight loss, boosts market competitionCHOSUNBIZ - Chosunbiz
Friday Five – Lilly's obesity oral could eat up competition, pill penalty pivot, tariff talk…and more - FirstWord Pharma
Experimental GLP-1 pill helped people with diabetes lose weight and lower blood sugar, Eli Lilly says - WTOP
Chugai Highlights Eli Lilly’s Promising Phase 3 Results for Orforglipron - TipRanks
Eli Lilly and Co (LLY) Stock Price, Trades & News - GuruFocus
Eli Lilly: Experimental GLP-1 pill for diabetes helped with weight loss, blood sugar - Yahoo
Post-Pfizer dropout, Lilly Achieves GLP-1 win in phase III - BioWorld MedTech
Eli Lilly shares jump 14% on positive results for its ’Ozempic in a pill’ - Investing.com
Eli Lilly Rallies Over 14%, Notches Best Day Since June 2000 On Oral Weight-Loss Drug Results: Analysts React - Benzinga
Lilly weight-loss pill works as well as Ozempic, shares surge - MSN
How Eli Lilly's GLP-1 pill could transform the weight-loss space - Yahoo Finance
Eli Lilly's Obesity Trial Triumph Boosts Shares, While UnitedHealth Stumbles - Finimize
U.S. Markets Closed Mixed Thursday As Eli Lilly Led, Webull Lagged - Barron's
Lilly soars after weight-loss pill results rival Ozempic’s - The Detroit News
Novo Nordisk May Lag Behind Eli Lilly In Cardiometabolic Race, Analyst Downgrades Stock - Benzinga
Lilly says new weight loss, diabetes drug in pill form could be game changer - Deseret News
Eli Lilly’s stock soars 13% after reporting positive data from trial of diabetes and weight-loss pill - MSN
Daily GLP-1 pill effective for diabetes and obesity, Eli Lilly says - AOL.com
Weight-loss drug news sends Eli Lilly stock soaring - TheStreet
Lilly shares soar on new weight-loss pill that looks to pass Ozempic - Orange County Register
Lilly’s First Pill for Diabetes, Weight Loss Shows Positive Study Results - WSJ
Novo Nordisk Stock Drops on Eli Lilly Oral Weight-Loss Drug Success, Downgrade - Yahoo Finance
Eli Lilly announces trial results of new weight loss, diabetes pill; stock booms - MSN
New Eli Lilly-made GLP-1 pill could work as well as its injectable Mounjaro, Zepbound - Washington Times
Eli Lilly daily diabetes pill could be as effective as Ozempic and Mounjaro, trial finds - Spectrum News
Lilly's Diabetes Pill Clears Major Trial, Analyst Points To Global Potential - Benzinga
Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide - Yahoo
Lilly’s obesity pill scores in large diabetes trial - BioPharma Dive
Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic - New York Post
Eli Lilly's new GLP-1 weight loss pill showed success in clinical trial - LiveNOW from FOX
Why Is Eli Lilly (LLY) Stock Rocketing Higher Today - Yahoo Finance
Eli Lilly Weight Loss Pill Is A GLP-1 Drug Without Injections - TODAY.com
Lilly Soars As Study Shows Weight-Loss Pill to Pass Ozempic - Yahoo Finance
Lilly Weight-Loss Pill Works as Well as Ozempic, Shares Surge - GV Wire
Market movers: UnitedHealth, Eli Lilly, Hertz, ReconAfrica... - Proactive Investors
Lilly’s Weight-Loss Pill Shakes Up the Market: What You Need to Know - RagingBull
Eli Lilly finds its weight-loss pill works just as well as Ozempic — and investors are loving it - AOL.com
Eli Lilly stock spikes as efficacy of new weight-loss pill rivals Ozempic - Dallas News
Eli Lilly's weight loss pill could be just as good as Ozempic — and the stock soars - Quartz
UnitedHealth tumbles, Eli Lilly climbs, TSMC holds outlook - Yahoo Finance
2.31%
7.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):